Greater Manchester Integrated Care has appointed a new Chief Executive.
Mark Fisher will take up the role, following a competitive national recruitment process, and will replace Sarah Fisher, who will continue her work as Interim Chief Officer until July 2022 – when Mark officially starts the role.
Mark has previously held chief executive and director-level roles including at the Department of Work and Pensions in leading on work to reduce child poverty, boosting skills investment for employment nationally and creating jobs for young people.
Also working extensively across Government and the public sector setting, Mark has served as director general and secretary to the Grenfell Tower Inquiry, as well as the Director of the Office for Civil Society and Innovation in the Cabinet Office.
Sir Richard Leese, Chair designate, NHS Greater Manchester Integrated Care Board, said: “Mark’s vast and varied experience means he will be an outstanding system leader, perfectly placed to drive forward our ambitious collective ambitions for the health and wellbeing of the people here.
“I have complete confidence that Mark will develop the full potential of our partnership working and, as a values-driven leader with extensive experience in leading and joining-up complex services, he will play a vital role in Greater Manchester’s recovery from the Covid-19 pandemic.
“I would like to thank Sarah Price, who will continue as interim chief officer for now, for her incredible professionalism, integrity and leadership over the last two years which have, without doubt, been our most challenging ever. She has played a key role in our region’s response to the pandemic and in building the foundations we need for a system which puts the health of our population at its heart.”
Commenting on his appointment, Mark said: “It is a huge privilege to be appointed as the first chief executive of NHS Greater Manchester Integrated Care.
“The region has a long history of collaboration and partnership working, and we now have a real opportunity to make further change: to better address health inequalities, further improve clinical outcomes, and contribute to the wider social and economic development of Greater Manchester.”
